194 related articles for article (PubMed ID: 26455327)
21. Chemotactic activation of Dictyostelium AGC-family kinases AKT and PKBR1 requires separate but coordinated functions of PDK1 and TORC2.
Liao XH; Buggey J; Kimmel AR
J Cell Sci; 2010 Mar; 123(Pt 6):983-92. PubMed ID: 20200230
[TBL] [Abstract][Full Text] [Related]
22. Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway.
Deng Q; Yu X; Xiao L; Hu Z; Luo X; Tao Y; Yang L; Liu X; Chen H; Ding Z; Feng T; Tang Y; Weng X; Gao J; Yi W; Bode AM; Dong Z; Liu J; Cao Y
Cell Death Dis; 2013 Sep; 4(9):e804. PubMed ID: 24052072
[TBL] [Abstract][Full Text] [Related]
23. Copper Promotes Tumorigenesis by Activating the PDK1-AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner.
Guo J; Cheng J; Zheng N; Zhang X; Dai X; Zhang L; Hu C; Wu X; Jiang Q; Wu D; Okada H; Pandolfi PP; Wei W
Adv Sci (Weinh); 2021 Sep; 8(18):e2004303. PubMed ID: 34278744
[TBL] [Abstract][Full Text] [Related]
24. Essential role of PDK1 in regulating endothelial cell migration.
Primo L; di Blasio L; Roca C; Droetto S; Piva R; Schaffhausen B; Bussolino F
J Cell Biol; 2007 Mar; 176(7):1035-47. PubMed ID: 17371830
[TBL] [Abstract][Full Text] [Related]
25. PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness.
Yang M; Li D; Chang Z; Yang Z; Tian Z; Dong Z
J Exp Med; 2015 Feb; 212(2):253-65. PubMed ID: 25624444
[TBL] [Abstract][Full Text] [Related]
26. Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy.
Han D; Wang W; Jeon JH; Shen T; Huang X; Yi P; Dong B; Yang F
PLoS Biol; 2023 Aug; 21(8):e3002227. PubMed ID: 37531320
[TBL] [Abstract][Full Text] [Related]
27. Potential inhibition of PDK1/Akt signaling by phenothiazines suppresses cancer cell proliferation and survival.
Choi JH; Yang YR; Lee SK; Kim SH; Kim YH; Cha JY; Oh SW; Ha JR; Ryu SH; Suh PG
Ann N Y Acad Sci; 2008 Sep; 1138():393-403. PubMed ID: 18837915
[TBL] [Abstract][Full Text] [Related]
28. Serine 396 of PDK1 is required for maximal PKB activation.
Moon Z; Wang Y; Aryan N; Mousseau DD; Scheid MP
Cell Signal; 2008 Nov; 20(11):2038-49. PubMed ID: 18718528
[TBL] [Abstract][Full Text] [Related]
29. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.
Schade B; Rao T; Dourdin N; Lesurf R; Hallett M; Cardiff RD; Muller WJ
J Biol Chem; 2009 Jul; 284(28):19018-26. PubMed ID: 19435886
[TBL] [Abstract][Full Text] [Related]
30. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.
Haga S; Ozaki M; Inoue H; Okamoto Y; Ogawa W; Takeda K; Akira S; Todo S
Hepatology; 2009 Jan; 49(1):204-14. PubMed ID: 19065678
[TBL] [Abstract][Full Text] [Related]
31. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.
Pal D; Outram SP; Basu A
Biochim Biophys Acta; 2013 Aug; 1830(8):4040-5. PubMed ID: 23562764
[TBL] [Abstract][Full Text] [Related]
33. ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway.
Ren D; Jia L; Li Y; Gong Y; Liu C; Zhang X; Wang N; Zhao Y
IUBMB Life; 2014 Apr; 66(4):300-8. PubMed ID: 24756995
[TBL] [Abstract][Full Text] [Related]
34. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.
Politz O; Siegel F; Bärfacker L; Bömer U; Hägebarth A; Scott WJ; Michels M; Ince S; Neuhaus R; Meyer K; Fernández-Montalván AE; Liu N; von Nussbaum F; Mumberg D; Ziegelbauer K
Int J Cancer; 2017 Jan; 140(2):449-459. PubMed ID: 27699769
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of PDK1 gene expression in esophageal cancer EC9706 cells by RNA interference and its effect on their malignant biological behavior].
Yu J; Chen KS; Li YN; Yang J; Zhao L
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):410-4. PubMed ID: 21875479
[TBL] [Abstract][Full Text] [Related]
36. Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity of PDK1 in Jurkat Cells.
Yang KJ; Piao L; Shin S; Shin SY; Li Y; Lee H; Tran Q; Park J; Hong S; Brazil DP; Hemmings BA; Kim SH; Park J
Anticancer Res; 2017 Oct; 37(10):5415-5423. PubMed ID: 28982851
[TBL] [Abstract][Full Text] [Related]
37. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
38. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
[TBL] [Abstract][Full Text] [Related]
39. Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.
Kim SH; Miller FR; Tait L; Zheng J; Novak RF
Int J Cancer; 2009 Jun; 124(12):2813-28. PubMed ID: 19291795
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
